GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » PB Ratio

Cleo Diagnostics (ASX:COV) PB Ratio : 3.66 (As of Jun. 09, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-09), Cleo Diagnostics's share price is A$0.30. Cleo Diagnostics's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.08. Hence, Cleo Diagnostics's PB Ratio of today is 3.66.

The historical rank and industry rank for Cleo Diagnostics's PB Ratio or its related term are showing as below:

ASX:COV' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 3.97
Current: 3.66

During the past 1 years, Cleo Diagnostics's highest PB Ratio was 3.97. The lowest was 0.00. And the median was 0.00.

ASX:COV's PB Ratio is ranked worse than
71.39% of 783 companies
in the Medical Devices & Instruments industry
Industry Median: 2.27 vs ASX:COV: 3.66

Back to Basics: PB Ratio


Cleo Diagnostics PB Ratio Historical Data

The historical data trend for Cleo Diagnostics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics PB Ratio Chart

Cleo Diagnostics Annual Data
Trend Jun23
PB Ratio
-

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23
PB Ratio - - 2.20

Competitive Comparison of Cleo Diagnostics's PB Ratio

For the Medical Devices subindustry, Cleo Diagnostics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cleo Diagnostics's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's PB Ratio falls into.



Cleo Diagnostics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Cleo Diagnostics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.30/0.082
=3.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Cleo Diagnostics  (ASX:COV) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Cleo Diagnostics PB Ratio Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cleo Diagnostics (ASX:COV) Business Description

Traded in Other Exchanges
N/A
Address
480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines